ARCHIVES

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 7 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

March 3, 1989

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

ASCO Weighs In On Tobacco Debate

September 19, 1997